| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| Cell Signaling Pathway Inhibitors |
Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of other pathways |
|
| Olaparib(CAS:763113-22-0) |
 |
|
|
Product No. |
|
TP1133A |
|
Name |
|
Olaparib |
|
Synonyms |
|
Azd2281,1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine |
|
CAS Number |
|
763113-22-0 |
|
Structure |
|
|
|
Brief Description |
|
Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5 nM/1 nM, 300-times less effective against tankyrase-1. Phase 3. |
|
Purity |
|
>99% |
|
Package |
|
5mg，10mg，20mg，50mg | |
|
|
|
|
|
